Old Web
English
Sign In
Acemap
>
authorDetail
>
Panfeng Tan
Panfeng Tan
Medicine
Internal medicine
in patient
Oncology
Randomized controlled trial
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II trial of surufatinib plus toripalimab for disease progression after first-line chemotherapy with platinum and fluoropyrimidine in advanced gastric or gastroesophageal junction adenocarcinoma.
2021
Journal of Clinical Oncology
Lin Shen
Ming Lu
Zhendong Chen
Feng Ye
Yanqiao Zhang
Zhiping Li
Xing Zhang
Fei Yin
Wei Chen
Wang Sheng
Yue Ma
Yaqin Zhao
De Sheng Weng
Xiaolei Yin
Jinghong Zhou
Haiyan Shi
Panfeng Tan
Weiguo Su
Show All
Source
Cite
Save
Citations (0)
Surufatinib in combination with toripalimab in patients with advanced neuroendocrine carcinoma: Results from a multicenter, open-label, single-arm, phase II trial.
2021
Journal of Clinical Oncology
Lin Shen
Xianjun Yu
Ming Lu
Xing Zhang
Ying Cheng
Yanqiao Zhang
Zhiping Li
Jianming Xu
De Sheng Weng
Chunjiao Wu
Yue Ma
Ke Cheng
Wen-Quan Wang
Heli Gao
Yi Li
Jinghong Zhou
Haiyan Shi
Panfeng Tan
Weiguo Su
Show All
Source
Cite
Save
Citations (0)
Preliminary results of a phase 1b study of fruquintinib plus sintilimab in advanced colorectal cancer.
2021
Journal of Clinical Oncology
Ye Guo
Weijie Zhang
Jieer Ying
Yanqiao Zhang
Yueyin Pan
Wensheng Qiu
Weiguo Su
Panfeng Tan
Hongyan Yin
Yan Wang
Yang Luo
Hui Zhou
Jin Li
Show All
Source
Cite
Save
Citations (2)
A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS WITH BOTULINUM TOXIN A FOR NEUROGENIC DETRUSOR OVERACTIVITY
2014
Tianhai Huang
Panfeng Tan
Keji Xie
Show All
Source
Cite
Save
Citations (0)
1